Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 9 of 9
Full-Text Articles in Psychology
Measuring Depression In Prostate Cancer Patients: Does The Scale Used Make A Difference?, Christopher Sharpley, Vicki Bitsika, David Christie, Myra Hunter
Measuring Depression In Prostate Cancer Patients: Does The Scale Used Make A Difference?, Christopher Sharpley, Vicki Bitsika, David Christie, Myra Hunter
Vicki Bitsika
This study investigated differences in the scores, relative severity and major depressive disorder (MDD) and subsyndromal depression status from three standardised self-report scales for depression in prostate cancer (PCa) patients. The Hospital Anxiety and Depression Scale Depression subscale (HADS-D), the Self-rating Depression Scale (SDS) and the Patient Health Questionnaire (PHQ-9) for depression were administered to a sample of 138 PCa patients via mail-out self-reports in Queensland, Australia during May 2014. Despite significant correlations between the total scores from the three scales, severity classification differed across the three scales and there was evidence of considerable underestimation of depression by the HADS-D …
Predictors Of Depression In Prostate Cancer Patients: A Comparison Of Psychological Resilience Versus Pre-Existing Anxiety And Depression, Christopher Sharpley, Vicki Bitsika, Addie Wootten, David Christie
Predictors Of Depression In Prostate Cancer Patients: A Comparison Of Psychological Resilience Versus Pre-Existing Anxiety And Depression, Christopher Sharpley, Vicki Bitsika, Addie Wootten, David Christie
Vicki Bitsika
Background: Previous anxiety and depression can influence current anxiety and depression, and psychological resilience may be a buffer against current anxiety and depression. However, despite the relevance of these two sets of predictors of anxiety and depression, and their potential in treatment planning, no reports have been published on their role in post-diagnosis anxiety and depression among prostate cancer (PCa) patients. Therefore, this study aimed to determine the roles of these predictors in a sample of men with prostate cancer. Method: Retrospective self-reports of anxiety and depression for how they were before receiving their diagnosis of PCa and at the …
Do Patient-Reported Androgen-Deprivation Therapy Side Effects Predict Anxiety And Depression Among Prostate Cancer Patients Undergoing Radiotherapy? Implications For Psychosocial Therapy Interventions, Christopher Sharpley, Vicki Bitsika, David Christie
Do Patient-Reported Androgen-Deprivation Therapy Side Effects Predict Anxiety And Depression Among Prostate Cancer Patients Undergoing Radiotherapy? Implications For Psychosocial Therapy Interventions, Christopher Sharpley, Vicki Bitsika, David Christie
Vicki Bitsika
Antiandrogen therapy (AAT) is a common adjunct treatment for prostate cancer (PCa) patients and has shown significant benefits to long-term outcomes from radiation or surgery. Although AAT has some adverse side effects and data from breast cancer patients indicate that such side effects from hormonal therapies may contribute to anxiety and depression and may also hinder AAT treatment compliance, this issue has not been investigated within a sample of PCa patients. This study explores the incidence of AAT side effects in a sample of PCa patients, the links between those side effects and anxiety and depression, the possible ways in …
How Prostate Cancer Patients Cope: Evaluation And Refinement Of The Prostate Cancer Patients' Coping Strategies Questionnaire, Christopher Sharpley, Vicki Bitsika, David Christie
How Prostate Cancer Patients Cope: Evaluation And Refinement Of The Prostate Cancer Patients' Coping Strategies Questionnaire, Christopher Sharpley, Vicki Bitsika, David Christie
Vicki Bitsika
Background: Prostate cancer (PCa) patients suffer from identifiable stressors that may cause them anxiety and/or depression. In a previous study, an initial exploration of the ways in which PCa patients seek to cope with those stressors was described. However, several methodological limitations prevented direct comparisons of the relative effectiveness of patients’ coping strategies. To further investigate this issue, a standardised format was used to present the most commonly-used coping strategies to a new sample of PCa patients and to compare the effectiveness of those strategies. Methods: A total of 147 PCa patients completed a background questionnaire and the Prostate Cancer …
Breast Cancer Patients' Preferences For Information: Different Sources At Different Times?, Christopher Sharpley, Vicki Bitsika, David Christie
Breast Cancer Patients' Preferences For Information: Different Sources At Different Times?, Christopher Sharpley, Vicki Bitsika, David Christie
Vicki Bitsika
Introduction: Information given to breast cancer patients may not universally reduce anxiety and assist treament compliance. One possible reason could be that patient preferences for specific information sources may change over time.Objectives: To compare breast cancer patients' preferred formats for receiving education about their disease and treatment soon after diagnosis versus about two years after that time.Methods: An anonymous survey of 253 breast cancer patients' evaluations of alternative information formats was conducted within one month of diagnosis, and data were compared to those collected in a previous study from patients who were abut two years post-diagnosis.Results: There were discrepancies between …
Variability In Anxiety And Depression Over Time Following Diagnosis In Patients With Prostate Cancer, Christoper Sharpley, David Christie, Vicki Bitsika
Variability In Anxiety And Depression Over Time Following Diagnosis In Patients With Prostate Cancer, Christoper Sharpley, David Christie, Vicki Bitsika
Vicki Bitsika
To determine the presence and nature of variability in anxiety and depression in patients with prostate cancer (PCa) over 3 years following diagnosis, 442 patients with PCa completed standardized anxiety and depression inventories via survey between 1 and 36 months after receiving their initial diagnosis. Data were analyzed from a series of 3-month cohorts, and results indicated that total scores and incidence of clinically significant anxiety and depression varied over time, but that this variability was restricted to specific subfactors of anxiety and depression. Provision of effective psychological treatment to patients with PCa is discussed.
Incidence And Nature Of Anxiety-Depression Comorbidity In Prostate Cancer Patients, Christoper Sharpley, Vicki Bitsika, David Christie
Incidence And Nature Of Anxiety-Depression Comorbidity In Prostate Cancer Patients, Christoper Sharpley, Vicki Bitsika, David Christie
Vicki Bitsika
Background: The aim of this study was to measure the incidence of anxiety-depression comorbidity among a sample of prostate cancer (PCa) patients and to investigate the total score, factor score and scale item differences across subgroups defined according to the presence of anxiety and/or depression. Methods: 491 PCa patients who had received their initial diagnosis between 1 and 113 months previously completed a survey of background variables, as well as the Zung Self-Rating Anxiety and Depression Scales (SAS, SDS). Results: Incidence of anxiety-depression comorbidity was nearly 16%, and higher than that previously reported in other samples. Although the directional differences …
'Why I Feel Bad': Refinement On The Effects Of Prostate Cancer Upon Lifestyle Questionnaire And An Initial Exploration Of Its Links With Anxiety And Depression Among Prostate Cancer Patients, Christopher Sharpley, Vicki Bitsika, David Christie
'Why I Feel Bad': Refinement On The Effects Of Prostate Cancer Upon Lifestyle Questionnaire And An Initial Exploration Of Its Links With Anxiety And Depression Among Prostate Cancer Patients, Christopher Sharpley, Vicki Bitsika, David Christie
Vicki Bitsika
Objective: To psychometrically refine a standardized scale for identifying those lifestyle changes that were most likely to contribute to anxiety and depression among prostate cancer (PCa) patients.
Methods: Three hundred and eighty-one PCa patients who had received their initial diagnosis between one and 96 months completed a survey of background variables, anxiety and depression inventories and the 36-item Effects of Prostate Cancer upon Lifestyle Questionnaire (EPCLQ).
Results: Levels of anxiety (24%) and depression (26%) were similar to those previously reported for PCa patients. The EPCLQ was shown to have satisfactory psychometric properties and significantly predicted anxiety and depression scores and …
Understanding The Causes Of Depression Among Prostate Cancer Patients: Development Of The Effects Of Prostate Cancer On Lifestyle Questionnaire, Christopher Sharpley, Vicki Bitsika, David Christie
Understanding The Causes Of Depression Among Prostate Cancer Patients: Development Of The Effects Of Prostate Cancer On Lifestyle Questionnaire, Christopher Sharpley, Vicki Bitsika, David Christie
Vicki Bitsika
Objective: Depression among prostate cancer patients remains a major source of distress for them and their families, has been linked with suicide, and has been shown to contribute to poorer longterm treatment outcomes. Most psychological assessment strategies focus upon the presence of depressive symptomatology without identifying the specific causal antecedents that lead to depression among this patient group, although this underlies effective individually-oriented treatment planning and delivery.
Method: 150 prostate cancer patients completed self reports on anxiety, depression and lifestyle changes that they had experienced as a result of receiving a diagnosis of, and treatment for their cancer. The principal …